Hedera Group Valuation

Q: What is the Fair Price of HEGR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

HEGR (SEK2.42) is trading below our estimate of [[fair value]] (SEK15.38)

Is HEGR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HEGR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HEGR (SEK2.42) is trading below our estimate of fair value (SEK15.38)

Significantly Below Fair Value: HEGR is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HEGR?

Key metric: As HEGR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HEGR. This is calculated by dividing HEGR's market cap by their current revenue.
What is HEGR's PS Ratio?
PS Ratio	0.06x
Sales	SEK 580.68m
Market Cap	SEK 36.06m

HEGR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.1x
Enterprise Value/EBITDA	19.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does HEGR's PS Ratio compare to its peers?

The above table shows the PS ratio for HEGR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	7x
NGS NGS Group	0.2x	n/a	SEK 77.4m
L2S Learning 2 Sleep L2S	3.7x	n/a	SEK 10.6m
DEDI Dedicare	0.3x	n/a	SEK 592.9m
POLAR PolarCool	23.9x	n/a	SEK 38.4m
HEGR Hedera Group	0.06x	n/a	SEK 36.1m

Price-To-Sales vs Peers: HEGR is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (7x).

Price to Sales Ratio vs Industry

How does HEGR's PS Ratio compare vs other companies in the European Healthcare Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	0.6x	10.8%
HEGR Hedera Group	0.06x	n/a	US$3.27m

7 Companies		Estimated Growth	Market Cap
Industry Avg.	0.6x	33.8%
HEGR Hedera Group	0.06x	n/a	US$3.27m

No more companies

Price-To-Sales vs Industry: HEGR is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Healthcare industry average (0.6x).

Price to Sales Ratio vs Fair Ratio

What is HEGR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HEGR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.06x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate HEGR's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Mentice

SEK 560.0m

Provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

MNTC

SEK 21.90

2.8%

-46.6%

Iconovo

SEK 80.5m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.06

2.4%

-45.1%

Dignitana

SEK 95.8m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.19

3.5%

-45.9%